THURSDAY, May 10 (HealthDay News) — A new weight-loss drug that is awaiting approval from the U.S. Food and Drug Administration showed promising results in a recent international trial, researchers report.
Continue Reading On yahoo.com »
FRIDAY, May 11 (HealthDay News) — Obese women often stop getting their periods, but new research suggests weight-loss surgery can help regulate their monthly cycles, while also stemming excessive hair growth and skin problems that often accompany significant weight gain.
Continue Reading On yahoo.com »
NEW YORK (Reuters) – One night when Lynn McAfee was 5 years old, her psychologically troubled mother left her at the side of a road as punishment for a now forgotten infraction. In the minutes before her mother’s car returned, the terrified girl looked toward the nearby houses on the suburban Philadelphia street and wondered if she should walk over and ask for help…
Continue Reading On yahoo.com »
THURSDAY, May 10 (HealthDay News) — An advisory panel to the U.S. Food and Drug Administration on Thursday recommended approval of the weight-loss medication lorcaserin, even though concerns remain about cardiovascular side effects.
Continue Reading On yahoo.com »
Lorcaserin, an investigational obesity drug, was given a positive recommendation by the Endocrinologic and Metabolic Drugs Advisory Committee, which advises the Food and Drug Administration (FDA). The Committee voted 18 to 4 in favor, with one abstention, in advising the FDA whether to approve the medication for obese or overweight individuals…
Continue Reading On medicalnewstoday.com »
